Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...

The retrospective study presented at ESMO 2024 involved about 2,400 patients with stage 3 or 4 non-small cell lung cancer.

A large team of microbiologists, pathologists and infectious diseases specialists affiliated with several institutions in the ...

He explained: “For more permanent pathogens ... Despite these challenges, mRNA technology can be used to express large and complex proteins that are difficult or impossible to generate with ...

A spokesperson for the company explained the difference of sa-RNA from mRNA: “The key differentiator of Ziphius’ sa-RNA technology is the higher concentration of RNA by amplification ...

The 2024 #NobelPrize in Physiology or Medicine focuses on the discovery of a vital regulatory mechanism used in cells to ...

An mRNA vaccine that targets several aspects of C. difficile’s ability to cause severe disease prevented major symptoms and death in mice.

Moderna, Inc, a global leader in the creation of the field of mRNA medicine through the advancement of mRNA technology, announced that the first participant in the US has been dosed in the Nova 301 ...

Engineers have discovered a simple and inexpensive means of directing lipid nanoparticles (LNPs), the revolutionary molecules that delivered the COVID-19 vaccines, to target specific tissues, ...

Discover Vicebio's molecular clamp technology as it completes a $100 million series B round for its bivalent vaccine against ...